暂无数据
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
美股期权个股详情
GRFS240517P7500
- 0.05
- 0.000.00%
延时15分钟行情收盘价 05/17 15:59 (美东)
0.00最高价0.00最低价
0.00今开0.05昨收0张成交量927张未平仓合约数7.50行权价0.00成交额518.62%隐含波动率-2.99%溢价2024/05/17到期日0.00内在价值100合约乘数-2天距到期日0.05时间价值100合约规模美式期权类型-0.2557Delta1.0091Gamma153.60杠杆倍数-2.2377Theta0.0000Rho-39.28有效杠杆0.0002Vega
分时
- 5日
- 日K
新闻
由于美国存托凭证在周五交易中小幅上涨，欧洲股市在美国交易
周五上午晚些时候，由于美国存托凭证小幅走高，欧洲股市在美国交易，标普欧洲精选ADR指数上涨0.29％，至1,426.43。索引设置为 c
6-K：外国发行人报告（业绩相关）
快讯 | Grifols董事长格兰兹曼表示首席财务官阿尔弗雷多·阿罗约将辞职；Grifols董事长将不再担任执行职务
基立福董事会主席Glanzmann表示：公司首席财务官（CFO） Alfredo Arroyo将离职
基立福董事会主席Glanzmann表示，公司首席财务官（CFO） Alfredo Arroyo将离职。（文章来源：财联社）
快讯 | Grifols第一季度净收入为16.3亿欧元，同比为15.6亿欧元；预计第一季度研发净投资为负9,050万欧元，同比下降（1.047亿欧元）；鉴于多项正在进行的举措，目前正在努力改善FCF指导；将举办投资者和分析师日...
快讯 | Grifols有望达到财年指导并减少债务
评论
$基立福(GRFS.US$ Notorious Short seller GOTHAM spread FUD and crashes price a few weeks back! And then others keep posting the hit piece! But you hardly see any stories that GRIFOLS has filed a lawsuit against GOTHAM for that accusation! Grrrr! Well here GOTHAM, take this! Not great but good start! At least IMO! (((((((((. Grifols Q1 Net Revenues €1.63 Billion Vs €1.56 Billion YoY; Sees Q1 R&D Negative Net Investment €90.5 M...
$基立福(GRFS.US$ MT Newswires· 3 mins ago
Grifols (GRF.MC) said Monday that the sale of its 20% stake in blood products company Shanghai RAAS to Chinese home appliance company Haier Group is expected to be completed by June.
The Spanish pharmaceutical company said both the buyer and seller secured the necessary domestic and overseas government approvals for the deal. It noted that the transaction still requires a compliance confirmation from the Shenzhen Stock Exchange.
Grifols (GRF.MC) said Monday that the sale of its 20% stake in blood products company Shanghai RAAS to Chinese home appliance company Haier Group is expected to be completed by June.
The Spanish pharmaceutical company said both the buyer and seller secured the necessary domestic and overseas government approvals for the deal. It noted that the transaction still requires a compliance confirmation from the Shenzhen Stock Exchange.
$基立福(GRFS.US$ April 22, 2024 Grifols achieves positive results from phase 4 study of Fanhdi® (double-inactivated human anti-hemophilic factor) in patients with von Willebrand Disease Download PDF Grifols’ Fanhdi showed it could be effective, safe and well tolerated in the management of bleeding episodes and for the prevention of bleeding during surgeries in patients with von Willebrand Disease (VWD) VWD, which is caused by a deficiency of von Willebrand factor in plasma, is the most common ...
$基立福(GRFS.US$ Grifols (GRF.MC) is set to launch a private offering of 1 billion euros of 7.5% senior secured notes due April 2030 for the redemption of senior unsecured notes due May 2025.
The Spanish pharmaceutical group said Tuesday the note offering is contingent upon the fulfillment of customary closing conditions.
The Spanish pharmaceutical group said Tuesday the note offering is contingent upon the fulfillment of customary closing conditions.
$基立福(GRFS.US$ International Medical Industries, Inc. Announces Partnership With Grifols for Enhanced Medication Safety!!! ((((( guess it may take some time to sink in ))))) Hehehe![]()
2
阅读更多